Lipoic acid increases glutamate uptake, glutamine synthetase activity and glutathione content in C6 astrocyte cell line

International Journal of Developmental Neuroscience

Volumn 31, Issue 3, 2013, Pages 165-170

  Kleinkauf Rocha, Juliana ^a,b   Bobermin, Larissa Daniele ^a   Machado, Priscila de Mattos ^b   Gonçalves, Carlos Alberto ^a   Gottfried, Carmem ^a   Quincozes Santos, André ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Fundacao de Apoio a Pesquisa e Estudos na Area de Saude FAPES   (Brazil)

Author keywords

C6 astrocyte cell line; Glutamate metabolism; Lipoic acid; Reactive oxygen species

Indexed keywords

GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTATHIONE; NITRIC OXIDE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL FUNCTION; CELL PROTECTION; CELL STRAIN; CELL STRAIN C6; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GLIA; NERVOUS SYSTEM PARAMETERS; NEUROMODULATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; ANIMAL; CELL LINE; DRUG EFFECT; METABOLISM; OXIDATIVE STRESS;

ANIMALS; ASTROCYTES; CELL LINE; GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; GLUTATHIONE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; THIOCTIC ACID;

EID: 84873824900     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2012.12.006     Document Type: Article

References (67)

1. Abib R.T., Quincozes-Santos A., Nardin P., Wofchuk S.T., Perry M.L., Goncalves C.A., Gottfried C. Epicatechin gallate increases glutamate uptake and S100B secretion in C6 cell lineage. Molecular and Cellular Biochemistry 2008, 310:153-158.
2. Aguirre N., Barrionuevo M., Ramirez M.J., Del Rio J., Lasheras B. Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity. Neuroreport 1999, 10:3675-3680.
3. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000, 32:1-14.
4. Banerjee R., Vitvitsky V., Garg S.K. The undertow of sulfur metabolism on glutamatergic neurotransmission. Trends in Biochemical Sciences 2008, 33:413-419.
5. Barbeito L.H., Pehar M., Cassina P., Vargas M.R., Peluffo H., Viera L., Estevez A.G., Beckman J.S. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Research. Brain Research Reviews 2004, 47:263-274.
6. Belanger M., Allaman I., Magistretti P.J. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metabolism 2011, 14:724-738.
7. Benda P., Lightbody J., Sato G., Levine L., Sweet W. Differentiated rat glial cell strain in tissue culture. Science 1968, 161:370-371.
8. Bianchi M.G., Rotoli B.M., Dall'Asta V., Gazzola G.C., Gatti R., Bussolati O. PKC-dependent stimulation of EAAT3 glutamate transporter does not require the integrity of actin cytoskeleton. Neurochemistry International 2006, 48:341-349.
9. Biewenga G.P., Haenen G.R., Bast A. The pharmacology of the antioxidant lipoic acid. General Pharmacology 1997, 29:315-331.
10. Browne R.W., Armstrong D. Reduced glutathione and glutathione disulfide. Methods in Molecular Biology 1998, 108:347-352.
11. Busse E., Zimmer G., Schopohl B., Kornhuber B. Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittel-Forschung 1992, 42:829-831.
12. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., Stella A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nature Reviews Neuroscience 2007, 8:766-775.
13. Castagne V., Gautschi M., Lefevre K., Posada A., Clarke P.G. Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Progress in Neurobiology 1999, 59:397-423.
14. Dal-Cim T., Martins W.C., Santos A.R., Tasca C.I. Guanosine is neuroprotective against oxygen/glucose deprivation in hippocampal slices via large conductance Ca(2)+-activated K+ channels, phosphatidilinositol-3 kinase/protein kinase B pathway activation and glutamate uptake. Neuroscience 2011, 183:212-220.
15. Danbolt N.C. Glutamate uptake. Progress in Neurobiology 2001, 65:1-105.
16. Davis K.E., Straff D.J., Weinstein E.A., Bannerman P.G., Correale D.M., Rothstein J.D., Robinson M.B. Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma. Journal of Neuroscience 1998, 18:2475-2485.
17. Day R.M., Suzuki Y.J. Cell proliferation, reactive oxygen and cellular glutathione. Dose Response 2005, 3:425-442.
18. De Araujo D.P., Lobato Rde F., Cavalcanti J.R., Sampaio L.R., Araujo P.V., Silva M.C., Neves K.R., Fonteles M.M., Sousa F.C., Vasconcelos S.M. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review. International Journal of Neuroscience 2010, 121:51-57.
19. de la Lastra C.A., Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochemical Society Transactions 2007, 35:1156-1160.
20. dos Santos A.Q., Nardin P., Funchal C., de Almeida L.M., Jacques-Silva M.C., Wofchuk S.T., Goncalves C.A., Gottfried C. Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. Archives of Biochemistry and Biophysics 2006, 453:161-167.
21. Gonzalez M.I., Kazanietz M.G., Robinson M.B. Regulation of the neuronal glutamate transporter excitatory amino acid carrier-1 (EAAC1) by different protein kinase C subtypes. Molecular Pharmacology 2002, 62:901-910.
22. Gottfried C., Tramontina F., Goncalves D., Goncalves C.A., Moriguchi E., Dias R.D., Wofchuk S.T., Souza D.O. Glutamate uptake in cultured astrocytes depends on age: a study about the effect of guanosine and the sensitivity to oxidative stress induced by H(2)O(2). Mechanisms of Ageing and Development 2002, 123:1333-1340.
23. Gutteridge J.M., Halliwell B. Antioxidants: molecules, medicines, and myths. Biochemical and Biophysical Research Communications 2010, 393:561-564.
24. Halassa M.M., Haydon P.G. Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annual Review of Physiology 2010, 72:335-355.
25. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo?. Free Radical Research 1996, 25:439-454.
26. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs and Aging 2001, 18:685-716.
27. Halliwell B. Oxidative stress and neurodegeneration: where are we now. Journal of Neurochemistry 2006, 97:1634-1658.
28. Han D., Sen C.K., Roy S., Kobayashi M.S., Tritschler H.J., Packer L. Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants. American Journal of Physiology 1997, 273:R1771-R1778.
29. Haramaki N., Han D., Handelman G.J., Tritschler H.J., Packer L. Cytosolic and mitochondrial systems for NADH- and NADPH-dependent reduction of alpha-lipoic acid. Free Radical Biology and Medicine 1997, 22:535-542.
30. Hertz L. Glutamate, a neurotransmitter-and so much more. A synopsis of Wierzba III. Neurochemistry International 2006, 48:416-425.
31. Hertz L., Zielke H.R. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends in Neurosciences 2004, 27:735-743.
32. Hevel J.M., Marletta M.A. Nitric-oxide synthase assays. Methods in Enzymology 1994, 233:250-258.
33. Hu J., Castets F., Guevara J.L., Van Eldik L.J. S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. Journal of Biological Chemistry 1996, 271:2543-2547.
34. Joseph J., Cole G., Head E., Ingram D. Nutrition, brain aging, and neurodegeneration. Journal of Neuroscience 2009, 29:12795-12801.
35. Kendig E.L., Le H.H., Belcher S.M. Defining hormesis: evaluation of a complex concentration response phenomenon. International Journal of Toxicology 2010, 29:235-246.
36. Kolgazi M., Jahovic N., Yuksel M., Ercan F., Alican I. Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats. Journal of Gastroenterology and Hepatology 2007, 22:1859-1865.
37. Kouda K., Iki M. Beneficial effects of mild stress (hormetic effects): dietary restriction and health. Journal of Physiological Anthropology 2010, 29:127-132.
38. Krizman-Genda E., Gonzalez M.I., Zelenaia O., Robinson M.B. Evidence that Akt mediates platelet-derived growth factor-dependent increases in activity and surface expression of the neuronal glutamate transporter, EAAC1. Neuropharmacology 2005, 49:872-882.
39. Lee M., Cho T., Jantaratnotai N., Wang Y.T., McGeer E., McGeer P.L. Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB Journal 2010, 24:2533-2545.
40. Lewerenz J., Klein M., Methner A. Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc- protects from oxidative glutamate toxicity. Journal of Neurochemistry 2006, 98:916-925.
41. Liu S., Baker J.C., Andrews P.C., Roche T.E. Recombinant expression and evaluation of the lipoyl domains of the dihydrolipoyl acetyltransferase component of the human pyruvate dehydrogenase complex. Archives of Biochemistry and Biophysics 1995, 316:926-940.
42. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
43. Mangoura D., Sakellaridis N., Jones J., Vernadakis A. Early and late passage C-6 glial cell growth: similarities with primary glial cells in culture. Neurochemical Research 1989, 14:941-947.
44. Mates J.M., Perez-Gomez C., Nunez de Castro I., Asenjo M., Marquez J. Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. International Journal of Biochemistry and Cell Biology 2002, 34:439-458.
45. McKenna M.C. The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain. Journal of Neuroscience Research 2007, 85:3347-3358.
46. Nakamura T., Lipton S.A. Molecular mechanisms of nitrosative stress-mediated protein misfolding in neurodegenerative diseases. Cellular and Molecular Life Sciences 2007, 64:1609-1620.
47. Ovesna Z., Horvathova-Kozics K. Structure-activity relationship of trans-resveratrol and its analogues. Neoplasma 2005, 52:450-455.
48. Packer L., Cadenas E. Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling. Journal of Clinical Biochemistry and Nutrition 2011, 48:26-32.
49. Packer L., Tritschler H.J. Alpha-lipoic acid: the metabolic antioxidant. Free Radical Biology and Medicine 1996, 20:625-626.
50. Perera J., Tan J.H., Jeevathayaparan S., Chakravarthi S., Haleagrahara N. Neuroprotective effects of alpha lipoic Acid on haloperidol-induced oxidative stress in the rat brain. Cell Biosci 2011, 1:12.
51. Pope S.A., Milton R., Heales S.J. Astrocytes protect against copper-catalysed loss of extracellular glutathione. Neurochemical Research 2008, 33:1410-1418.
52. Quincozes-Santos A., Andreazza A.C., Nardin P., Funchal C., Goncalves C.A., Gottfried C. Resveratrol attenuates oxidative-induced DNA damage in C6 Glioma cells. Neurotoxicology 2007, 28:886-891.
53. Quincozes-Santos A., Bobermin L.D., Kleinkauf-Rocha J., Souza D.O., Riesgo R., Goncalves C.A., Gottfried C. Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:11-15.
54. Quincozes-Santos A., Gottfried C. Resveratrol modulates astroglial functions: neuroprotective hypothesis. Annals of the New York Academy of Sciences 2011, 1215:72-78.
55. Quincozes-Santos A., Nardin P., de Souza D.F., Gelain D.P., Moreira J.C., Latini A., Goncalves C.A., Gottfried C. The janus face of resveratrol in astroglial cells. Neurotoxicity Research 2009, 16:30-41.
56. Reed L.J., Hackert M.L. Structure-function relationships in dihydrolipoamide acyltransferases. Journal of Biological Chemistry 1990, 265:8971-8974.
57. Sabharwal A.K., May J.M. alpha-Lipoic acid and ascorbate prevent LDL oxidation and oxidant stress in endothelial cells. Molecular and Cellular Biochemistry 2008, 309:125-132.
58. Salinthone S., Schillace R.V., Tsang C., Regan J.W., Bourdette D.N., Carr D.W. Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and -independent mechanisms. Journal of Nutritional Biochemistry 2011, 22:681-690.
59. Schulz J.B., Lindenau J., Seyfried J., Dichgans J. Glutathione, oxidative stress and neurodegeneration. European Journal of Biochemistry 2000, 267:4904-4911.
60. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB Journal 1996, 10:709-720.
61. Spector R. Nutrient transport systems in brain: 40 years of progress. Journal of Neurochemistry 2009, 111:315-320.
62. Trotti D., Danbolt N.C., Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?. Trends in Pharmacological Sciences 1998, 19:328-334.
63. Tuttle K.R., Anderberg R.J., Cooney S.K., Meek R.L. Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet. American Journal of Nephrology 2009, 29:171-180.
64. Veenman L., Bode J., Gaitner M., Caballero B., Pe'er Y., Zeno S., Kietz S., Kugler W., Lakomek M., Gavish M. Effects of 18-kDa translocator protein knockdown on gene expression of glutamate receptors, transporters, and metabolism, and on cell viability affected by glutamate. Pharmacogenetics and Genomics 2012, 22:606-619.
65. Wang D.D., Bordey A. The astrocyte odyssey. Progress in Neurobiology 2008, 86:342-367.
66. Xia E.Q., Deng G.F., Guo Y.J., Li H.B. Biological activities of polyphenols from grapes. International Journal of Molecular Sciences 2010, 11:622-646.
67. Ziegler D., Hanefeld M., Ruhnau K.J., Meissner H.P., Lobisch M., Schutte K., Gries F.A. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995, 38:1425-1433.